Table S2. Risk factors of in-hospital mortality in patients with infection, by univariate and multivariate regression analysis.
Variables | Control | Case | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|---|
Crude OR (95% CI) | Adjusted ORa (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Age groups (years), n | 1,363 | 353 | 1.05 (1.03–1.06) | 1.04 (1.02–1.05) | 1.05 (1.03–1.06) | 1.04 (1.02–1.05) | |
BMI (kg/m2), n | |||||||
18.5–24.9 | 390 | 56 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | |
<18.5 | 90 | 29 | 2.24 (1.36–3.71) | 1.80 (0.96–3.41) | 2.24 (1.36–3.71) | 1.84 (0.97–3.50) | |
>24.9 | 229 | 32 | 0.97 (0.61–1.55) | 1.39 (0.78–2.48) | 0.97 (0.61–1.55) | 1.37 (0.77–2.46) | |
Bedriddenb | 654 | 236 | 2.51 (1.83–3.45) | 1.62 (1.08–2.43) | 2.51 (1.83–3.45) | 1.64 (1.09–2.47) | |
Comorbidities, n | |||||||
Hypertension | 730 | 220 | 1.43 (1.13–1.82) | 1.43 (1.13–1.82) | |||
Chronic heart disease | 409 | 141 | 1.44 (1.14–1.83) | 1.44 (1.14–1.83) | |||
Chronic kidney disease | 53 | 25 | 1.88 (1.15–3.08) | 1.88 (1.15–3.08) | |||
Malignancy | 175 | 99 | 2.65 (2.00–3.51) | 3.52 (2.42–5.13) | 2.65 (2.00–3.51) | 3.59 (2.46–5.23) | |
Groups, n | |||||||
Sepsis (vs. nonsepsis) | 636 | 299 | 6.33 (4.65–8.62) | 3.83 (2.68–5.47) | |||
qSOFA ≥2 (vs. qSOFA <2) | 337 | 303 | 18.45 (13.35–25.50) | 14.06 (9.97–19.83) | |||
qSOFA(−)Sepsis(−) | 594 | 16 | 1.00 (ref) | 1.00 (ref) | |||
qSOFA(−)Sepsis(+) | 432 | 34 | 2.71 (1.48–4.97) | 2.55 (1.37–4.75) | |||
qSOFA(+)Sepsis(−) | 133 | 38 | 10.61 (5.74–19.59) | 9.20 (4.86–17.40) | |||
qSOFA(+)Sepsis(+) | 204 | 265 | 48.23 (28.41–81.85) | 41.89 (24.22–72.44) |
a, adjusted for gender, age in age categories (18–74, 75–83 and ≥84 years), comorbidities such as malignancy and the disease related groups; b, BMI could not be calculated because these patients were bedridden. CI, confidence interval; OR, odds ratio; SOFA, sequential organ failure assessment.